Association of decreased sex hormone binding globulin and cardiovascular risk factors.
- 1 January 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 9 (1) , 136-143
- https://doi.org/10.1161/01.atv.9.1.136
Abstract
Sex hormones play a major role in determining the risk of cardiovascular disease. While earlier studies have shown that reduced sex hormone binding globulin (SHBG) is associated with increased glucose and insulin concentrations in premenopausal women, few data exist on the relationship of SHBG to other cardiovascular risk factors in women. We hypothesized that decreased SHBG would be associated with an atherogenic pattern of cardiovascular risk factors. We measured total testosterone, total estradiol and SHBG, lipids and lipoproteins, glucose and insulin, and systolic and diastolic blood pressure in 96 premenopausal women. Although total testosterone and total estradiol were not related to cardiovascular risk factors, SHBG was negatively associated with triglyceride concentration (r = -0.37) and positively associated with high density lipoprotein cholesterol (HDLC) (r = 0.42). After adjustment for overall adiposity (body mass index) and upper body adiposity (as measured by the ratio of waist-to-hip circum...This publication has 31 references indexed in Scilit:
- Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy finnish menMetabolism, 1986
- Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in menThe American Journal of Cardiology, 1984
- Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.Journal of Clinical Investigation, 1983
- Relationship of plasma HDL-Cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and womenMetabolism, 1983
- Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosisPublished by Elsevier ,1982
- ABNORMAL SEX STEROID SECRETION AND BINDING IN MASSIVELY OBESE WOMENClinical Endocrinology, 1980
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMENThe Lancet, 1978
- Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.Journal of Clinical Investigation, 1977